Skip to main content

Advertisement

ADVERTISEMENT

Conference Coverage

For patients with Behçet disease, ophthalmological involvement is one of the most feared manifestations.
Conference Coverage
11/23/2021
A study presented at the ACR 2021 Convergence found that among patients with Behçet’s disease, the most frequent ocular manifestations were uveitis and retinal vasculitis.
A study presented at the ACR 2021 Convergence found that among patients with Behçet’s disease, the most frequent ocular manifestations were uveitis and retinal vasculitis.
A study presented at the ACR...
11/23/2021
Autoimmune
CT
Conference Coverage
11/12/2021
An abstract presented at the American College of Rheumatology 2021 Convergence validated Total-Body 18F-FDG PET/CT imaging for accurately diagnosing psoriatic arthritis.
An abstract presented at the American College of Rheumatology 2021 Convergence validated Total-Body 18F-FDG PET/CT imaging for accurately diagnosing psoriatic arthritis.
An abstract presented at the...
11/12/2021
Rheumatology & Arthritis
xray
Conference Coverage
11/06/2021
Specific subtypes of symptomatic multi-joint osteoarthritis, in which at least one joint site is symptomatic, are associated with varying decrements in self-reported physical function.
Specific subtypes of symptomatic multi-joint osteoarthritis, in which at least one joint site is symptomatic, are associated with varying decrements in self-reported physical function.
Specific subtypes of symptomatic...
11/06/2021
Rheumatology & Arthritis

Advertisement

Dr Elizabeth Wallace is a specialist on psoriasis. She presented emerging novel treatments for plaque psoriasis.
Conference Coverage
09/17/2021

Jessica Garlewicz, Associate Digital Editor

Jessica Garlewicz, Associate Digital ...
On the second day of Dermatology Week 2021, Dr Elizabeth Wallace introduced new, emerging therapies for the treatment of psoriasis. Read about her session highlights here.
On the second day of Dermatology Week 2021, Dr Elizabeth Wallace introduced new, emerging therapies for the treatment of psoriasis. Read about her session highlights here.
On the second day of Dermatology...
09/17/2021
The Dermatologist
Addressing Clinical Challenges in the Management of SLE With Dr Petri
Conference Coverage
04/18/2021
The early and accurate diagnosis is essential in the management of systemic lupus erythematosus, according to Michelle Petri, MD, who spoke at the virtual Interdisciplinary Autoimmune Summit on April 17, 2021.
The early and accurate diagnosis is essential in the management of systemic lupus erythematosus, according to Michelle Petri, MD, who spoke at the virtual Interdisciplinary Autoimmune Summit on April 17, 2021.
The early and accurate diagnosis...
04/18/2021
Autoimmune
IMID-JAK Pearls from Dr Ruth Ann Vleugels
Conference Coverage
04/18/2021
At the Interdisciplinary Autoimmune Summit, Ruth Ann Vleugels, MD, MPH, MBA, presented “Strategies for Improving IMID Outcomes: The Potential of JAK Inhibitors,” sharing a number of pearls when it comes to utilizing JAK inhibitors for the...
At the Interdisciplinary Autoimmune Summit, Ruth Ann Vleugels, MD, MPH, MBA, presented “Strategies for Improving IMID Outcomes: The Potential of JAK Inhibitors,” sharing a number of pearls when it comes to utilizing JAK inhibitors for the...
At the Interdisciplinary...
04/18/2021
Autoimmune

Advertisement

The Future of Cell Therapeutics for Autoimmune Diseases
Conference Coverage
07/12/2020
At IAS 2020, Biju Parekkadan, PhD, presented the latest evidence for the use of human cell and cellular therapeutics and how it may be used one day to treat patients with autoimmune diseases.
At IAS 2020, Biju Parekkadan, PhD, presented the latest evidence for the use of human cell and cellular therapeutics and how it may be used one day to treat patients with autoimmune diseases.
At IAS 2020, Biju Parekkadan,...
07/12/2020
Autoimmune
Optimizing Treatment Regimens in Immune-Mediated Diseases
Conference Coverage
07/12/2020
Research demonstrates that trough drug concentrations correlate to more positive outcomes in patients with immune-mediated diseases. At IAS 2020, David Hudesman, MD, and Adam Cheifetz, MD, discussed the relative benefits of therapeutic drug...
Research demonstrates that trough drug concentrations correlate to more positive outcomes in patients with immune-mediated diseases. At IAS 2020, David Hudesman, MD, and Adam Cheifetz, MD, discussed the relative benefits of therapeutic drug...
Research demonstrates that...
07/12/2020
Autoimmune
Behçet Disease Presents Complex Diagnostic Challenge
Conference Coverage
07/12/2020
Patients with Behçet disease may wait 9 years for a definitive diagnosis. Delfin Santos, MD, explained why this disease is so difficult to identify in his presentation at the virtual IAS 2020 meeting.
Patients with Behçet disease may wait 9 years for a definitive diagnosis. Delfin Santos, MD, explained why this disease is so difficult to identify in his presentation at the virtual IAS 2020 meeting.
Patients with Behçet disease may...
07/12/2020
Autoimmune

Advertisement

Dr Taft Discusses the Role of CBT for Patients With Autoimmune Diseases
Conference Coverage
07/12/2020
At IAS 2020, Tiffany Taft, PhD, discusses how cognitive behavioral therapy can help patients with autoimmune disease-related mental health symptoms, as well as how and when to refer patients.
At IAS 2020, Tiffany Taft, PhD, discusses how cognitive behavioral therapy can help patients with autoimmune disease-related mental health symptoms, as well as how and when to refer patients.
At IAS 2020, Tiffany Taft, PhD,...
07/12/2020
Autoimmune

Advertisement